Author: Aly, Ragia; Gupta, Sachin; Singh, Balraj; Kaur, Parminder; Kim, Kunhwa; Gupta, Sorab
Title: The use of direct acting oral anticoagulants in patients with COVID-19 infection Cord-id: ob19z91f Document date: 2021_3_23
ID: ob19z91f
Snippet: The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation, joint replacement surgeries and acute DVT/PE, etc. In the present times, DOACs are possibly one of the most widely prescribed medications in the developed world. The worldwide epidemic caused by COVID-19 caused significant changes in the practice o
Document: The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation, joint replacement surgeries and acute DVT/PE, etc. In the present times, DOACs are possibly one of the most widely prescribed medications in the developed world. The worldwide epidemic caused by COVID-19 caused significant changes in the practice of medicine worldwide. Patients who developed severe respiratory illness caused by COVID-19 were noted to develop a wide range of complications, including both arterial and venous thromboembolic complications including deep vein thrombosis and pulmonary embolism, etc. This review is an attempt to identify the role of DOACs in the treatment and prevention of these complications as well as the safety of continuing therapy with DOACs in the patients who were receiving them before contracting the infection.
Search related documents:
Co phrase search for related documents- acute illness and lmwh weight heparin: 1, 2
- acute illness and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
- acute illness and low molecular lmwh weight heparin: 1, 2
- lmwh weight heparin and lopinavir ritonavir: 1, 2, 3
- lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- lmwh weight heparin and lupus anticoagulant: 1
- lopinavir ritonavir and low molecular lmwh weight heparin: 1, 2, 3
- low molecular lmwh weight heparin and lupus anticoagulant: 1
Co phrase search for related documents, hyperlinks ordered by date